Form 8-K - Current report:
SEC Accession No. 0001213900-14-000029
Filing Date
2014-01-03
Accepted
2014-01-03 16:17:28
Documents
1
Period of Report
2013-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k122713_actiniumphar.htm 8-K 27626
  Complete submission text file 0001213900-14-000029.txt   28823
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 14505981
SIC: 6770 Blank Checks